Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells
✍ Scribed by Anita S. -F. Chong; Penelope N. Markham; Howard M. Gebel; Steven D. Bines; John S. Coon
- Book ID
- 105300025
- Publisher
- Springer-Verlag
- Year
- 1993
- Tongue
- English
- Weight
- 795 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Most leukemias that exhibit P‐glycoprotein (P‐gp)‐associated multidrug resistance (MDR) exhibit reduced susceptibility to immune cytotoxicity mediated by natural killer (NK) cells. To explore this phenomenon we investigated N6/ADR, a doxorubicin‐selected, P‐gp‐positive variant of the hu
A range of anthracyclines and related compounds were evaluated for activity against murine and human cell lines exhibiting multidrug resistance (MDR). Cell lines used were the NCI-H69 human small-cell lung cancer line and the EMT6 murine mammary tumour line, together with their multidrug-resistant c